A Study of Language Interpretation Solutions for People With Breast Cancer
Start Date
12/2/2024
Completion Date
12/2/2029
Summary
The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Remote Simultaneous Medical Interpreting/RSMI
Remote Consecutive Medical Interpreting/RCMI
Remote Consecutive Video Medical Interpreting/RCVI
Conditions
Locations
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey 07920
United States
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey 07748
United States
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey 07645
United States
Memorial Sloan Kettering Suffolk- Commack (Consent Only)
Commack, New York 11725
United States
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, New York 10604
United States
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)
New York, New York 10035
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Rockville Centre, New York 11553
United States